文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

浅表性纤维瘤病在遗传学上与深部纤维瘤病不同。

Superficial fibromatoses are genetically distinct from deep fibromatoses.

作者信息

Montgomery E, Lee J H, Abraham S C, Wu T T

机构信息

Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2196, USA.

出版信息

Mod Pathol. 2001 Jul;14(7):695-701. doi: 10.1038/modpathol.3880374.


DOI:10.1038/modpathol.3880374
PMID:11455002
Abstract

Whereas deep fibromatoses (abdominal, extra-abdominal, mesenteric) display locally aggressive behavior, superficial fibromatoses typically remain small and less likely to recur despite essentially identical morphology. Somatic beta-catenin or APC gene mutations have been reported in < or =74% of sporadic deep fibromatoses and in virtually 100% of Gardner syndrome-associated fibromatoses, whereas genetic events in superficial fibromatoses remain less well characterized. We performed immunohistochemical staining for beta-catenin on 29 superficial fibromatoses (22 palmar, 5 plantar, 1 penile, and 1 infantile digital fibromatosis) and 5 deep fibromatoses. Mutations of beta-catenin and APC genes were analyzed in cases of superficial fibromatoses by direct DNA sequencing of the beta-catenin gene on Exon 3 encompassing the GSK-3 36 phosphorylation region and of the APC gene on the mutation cluster region. Nuclear accumulation of beta-catenin was present in 86% (25/29) of superficial fibromatosis cases ranging from 5 to 100% of nuclei (mean, 13%; median, 10%), though in a minority of nuclei in most examples. Deep fibromatoses had 60 to 100% nuclear staining in all five cases. No somatic mutations of beta-catenin or APC genes were identified in any of the superficial fibromatoses. In contrast to deep fibromatoses, superficial fibromatoses lack beta-catenin and APC gene mutations; the significance of focal nuclear beta-catenin accumulation is unclear. This difference may account inpart for their divergent clinical manifestations despite their morphologic resemblance to deep fibromatoses.

摘要

尽管深部纤维瘤病(腹部、腹外、肠系膜)表现出局部侵袭性,但浅表纤维瘤病通常较小,尽管形态基本相同,但复发可能性较小。据报道,散发性深部纤维瘤病中≤74%以及几乎100%的与加德纳综合征相关的纤维瘤病存在体细胞β-连环蛋白或APC基因突变,而浅表纤维瘤病中的基因事件特征尚不明确。我们对29例浅表纤维瘤病(22例掌部、5例跖部、1例阴茎部和1例婴儿指部纤维瘤病)和5例深部纤维瘤病进行了β-连环蛋白免疫组化染色。通过对包含GSK-3β磷酸化区域的外显子3上的β-连环蛋白基因以及突变簇区域的APC基因进行直接DNA测序,分析浅表纤维瘤病病例中的β-连环蛋白和APC基因突变。β-连环蛋白核内积聚存在于86%(25/29)的浅表纤维瘤病病例中,细胞核比例为5%至100%(平均13%;中位数10%),不过在大多数病例中仅为少数细胞核。所有5例深部纤维瘤病均有60%至100%的核染色。在任何浅表纤维瘤病中均未发现β-连环蛋白或APC基因的体细胞突变。与深部纤维瘤病不同,浅表纤维瘤病缺乏β-连环蛋白和APC基因突变;局灶性核β-连环蛋白积聚的意义尚不清楚。尽管浅表纤维瘤病与深部纤维瘤病形态相似,但这种差异可能部分解释了它们不同的临床表现。

相似文献

[1]
Superficial fibromatoses are genetically distinct from deep fibromatoses.

Mod Pathol. 2001-7

[2]
Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor).

Oncogene. 1999-11-11

[3]
Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).

Am J Pathol. 1997-8

[4]
Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway.

Hum Pathol. 2002-1

[5]
Sporadic fundic gland polyposis: a clinical, histological, and molecular analysis.

Mod Pathol. 2002-7

[6]
Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.

Am J Surg Pathol. 2007-9

[7]
Mutations in beta-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomas.

Mod Pathol. 2000-10

[8]
Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.

Cancer Res. 2001-11-15

[9]
Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway.

Mod Pathol. 2002-3

[10]
beta-catenin nuclear expression correlates with cyclin D1 overexpression in sporadic desmoid tumours.

J Pathol. 2001-9

引用本文的文献

[1]
Orthopedic Dermatopathies: Skin Manifestations in Orthopedic Conditions.

J Orthop Sports Med. 2024

[2]
Diagnosis and Management of Desmoid Fibromatosis of the Breast.

World J Oncol. 2024-6

[3]
C-X-C domain ligand 14-mediated stromal cell-macrophage interaction as a therapeutic target for hand dermal fibrosis.

Commun Biol. 2023-11-18

[4]
Sorafenib in Dupuytren and Ledderhose Disease.

Oncologist. 2022-3-11

[5]
Sensory innervation of the human palmar aponeurosis in healthy individuals and patients with palmar fibromatosis.

J Anat. 2022-5

[6]
Massive congenital cervicofacial desmoid-type fibromatosis in a 5-month-old infant.

J Surg Case Rep. 2021-5-27

[7]
Nuclear TFE3 expression is a diagnostic marker for Desmoid-type fibromatosis.

Diagn Pathol. 2019-5-1

[8]
Fibromatosis - immunohistochemical evaluation, differential diagnosis from gastrointestinal tumors, and other mesenchymal tumours.

Prz Gastroenterol. 2019

[9]
T2 signal intensity as an imaging biomarker for patients with superficial Fibromatoses of the hands (Dupuytren's disease) and feet (Ledderhose disease) undergoing definitive electron beam irradiation.

Skeletal Radiol. 2018-2

[10]
Meta-Analysis of Genome-Wide Association Studies and Network Analysis-Based Integration with Gene Expression Data Identify New Suggestive Loci and Unravel a Wnt-Centric Network Associated with Dupuytren's Disease.

PLoS One. 2016-7-28

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索